Cargando…

Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models

BACKGROUND: Anti-glomerular basement membrane nephritis and Goodpasture syndrome result from autoantibody (Ab)-mediated destruction of kidney and lung. Ab target the noncollagenous 1 (NC1) domain of alpha3(IV) collagen, but little is known about Ab origins or structure. This ignorance is due in part...

Descripción completa

Detalles Bibliográficos
Autores principales: Worni-Schudel, Inge M, Clark, Amy G, Chien, Tiffany, Hwang, Kwan-Ki, Chen, Benny J, Foster, Mary H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467618/
https://www.ncbi.nlm.nih.gov/pubmed/26048777
http://dx.doi.org/10.1186/s12967-015-0539-4
_version_ 1782376387448930304
author Worni-Schudel, Inge M
Clark, Amy G
Chien, Tiffany
Hwang, Kwan-Ki
Chen, Benny J
Foster, Mary H
author_facet Worni-Schudel, Inge M
Clark, Amy G
Chien, Tiffany
Hwang, Kwan-Ki
Chen, Benny J
Foster, Mary H
author_sort Worni-Schudel, Inge M
collection PubMed
description BACKGROUND: Anti-glomerular basement membrane nephritis and Goodpasture syndrome result from autoantibody (Ab)-mediated destruction of kidney and lung. Ab target the noncollagenous 1 (NC1) domain of alpha3(IV) collagen, but little is known about Ab origins or structure. This ignorance is due in part to the inability to recover monoclonal Ab by transformation of patients’ blood cells. The aim of this study was to assess the suitability of two humanized models for this purpose. METHODS: NOD-scid-gamma immunodeficient mice were engrafted either with human CD34+ hematopoietic stem cells (HSC) (Hu-HSC mice) and immunized with alpha3(IV)NC1 collagen containing the Goodpasture epitopes or with nephritis patients’ peripheral blood leukocytes (PBL) (Hu-PBL mice). After in vivo immune cell development and/or expansion, recovered human B cells were Epstein Barr virus (EBV)-transformed, screened for antigen (Ag) binding, electrofused with a mouse–human heterohybridoma, subcloned, and human Ab RNA sequenced by PCR after reverse transcription to cDNA. Flow cytometry was used to assess human B cell markers and differentiation in Hu-PBL mice. RESULTS: Sequence analysis of a human Ab derived from an immunized Hu-HSC mouse and reactive with alpha3(IV)NC1 collagen reveals that it is encoded by unmutated heavy and light chain genes. The heavy chain complementarity determining region 3, a major determinant of Ag binding, contains uncommon motifs, including an N-region somatically-introduced highly hydrophobic tetrapeptide and dual cysteines encoded by a uniquely human IGHD2-2 Ab gene segment that lacks a murine counterpart. Comparison of human and mouse autoantibodies suggests that structurally similar murine Ab may arise by convergent selection. In contrast to the Hu-HSC model, transformed human B cells are rarely recovered from Hu-PBL mice, in which human B cells terminally differentiate and lose expression of EBV receptor CD21, thus precluding their transformation and recovery. CONCLUSIONS: Hu-HSC mice reveal that potentially pathogenic B cells bearing unmutated Ig receptors reactive with the NC1 domain on alpha3(IV) collagen can be generated in, and not purged from, the human preimmune repertoire. Uniquely human gene elements are recruited to generate the antigen binding site in at least a subset of these autoantibodies, indicating that humanized models may provide insights inaccessible using conventional mouse models. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0539-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4467618
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44676182015-06-16 Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models Worni-Schudel, Inge M Clark, Amy G Chien, Tiffany Hwang, Kwan-Ki Chen, Benny J Foster, Mary H J Transl Med Research BACKGROUND: Anti-glomerular basement membrane nephritis and Goodpasture syndrome result from autoantibody (Ab)-mediated destruction of kidney and lung. Ab target the noncollagenous 1 (NC1) domain of alpha3(IV) collagen, but little is known about Ab origins or structure. This ignorance is due in part to the inability to recover monoclonal Ab by transformation of patients’ blood cells. The aim of this study was to assess the suitability of two humanized models for this purpose. METHODS: NOD-scid-gamma immunodeficient mice were engrafted either with human CD34+ hematopoietic stem cells (HSC) (Hu-HSC mice) and immunized with alpha3(IV)NC1 collagen containing the Goodpasture epitopes or with nephritis patients’ peripheral blood leukocytes (PBL) (Hu-PBL mice). After in vivo immune cell development and/or expansion, recovered human B cells were Epstein Barr virus (EBV)-transformed, screened for antigen (Ag) binding, electrofused with a mouse–human heterohybridoma, subcloned, and human Ab RNA sequenced by PCR after reverse transcription to cDNA. Flow cytometry was used to assess human B cell markers and differentiation in Hu-PBL mice. RESULTS: Sequence analysis of a human Ab derived from an immunized Hu-HSC mouse and reactive with alpha3(IV)NC1 collagen reveals that it is encoded by unmutated heavy and light chain genes. The heavy chain complementarity determining region 3, a major determinant of Ag binding, contains uncommon motifs, including an N-region somatically-introduced highly hydrophobic tetrapeptide and dual cysteines encoded by a uniquely human IGHD2-2 Ab gene segment that lacks a murine counterpart. Comparison of human and mouse autoantibodies suggests that structurally similar murine Ab may arise by convergent selection. In contrast to the Hu-HSC model, transformed human B cells are rarely recovered from Hu-PBL mice, in which human B cells terminally differentiate and lose expression of EBV receptor CD21, thus precluding their transformation and recovery. CONCLUSIONS: Hu-HSC mice reveal that potentially pathogenic B cells bearing unmutated Ig receptors reactive with the NC1 domain on alpha3(IV) collagen can be generated in, and not purged from, the human preimmune repertoire. Uniquely human gene elements are recruited to generate the antigen binding site in at least a subset of these autoantibodies, indicating that humanized models may provide insights inaccessible using conventional mouse models. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0539-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-06 /pmc/articles/PMC4467618/ /pubmed/26048777 http://dx.doi.org/10.1186/s12967-015-0539-4 Text en © Worni-Schudel et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Worni-Schudel, Inge M
Clark, Amy G
Chien, Tiffany
Hwang, Kwan-Ki
Chen, Benny J
Foster, Mary H
Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models
title Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models
title_full Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models
title_fullStr Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models
title_full_unstemmed Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models
title_short Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models
title_sort recovery of a human natural antibody against the noncollagenous-1 domain of type iv collagen using humanized models
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467618/
https://www.ncbi.nlm.nih.gov/pubmed/26048777
http://dx.doi.org/10.1186/s12967-015-0539-4
work_keys_str_mv AT wornischudelingem recoveryofahumannaturalantibodyagainstthenoncollagenous1domainoftypeivcollagenusinghumanizedmodels
AT clarkamyg recoveryofahumannaturalantibodyagainstthenoncollagenous1domainoftypeivcollagenusinghumanizedmodels
AT chientiffany recoveryofahumannaturalantibodyagainstthenoncollagenous1domainoftypeivcollagenusinghumanizedmodels
AT hwangkwanki recoveryofahumannaturalantibodyagainstthenoncollagenous1domainoftypeivcollagenusinghumanizedmodels
AT chenbennyj recoveryofahumannaturalantibodyagainstthenoncollagenous1domainoftypeivcollagenusinghumanizedmodels
AT fostermaryh recoveryofahumannaturalantibodyagainstthenoncollagenous1domainoftypeivcollagenusinghumanizedmodels